Donepezil for cognitive impairment in Parkinson's disease: A randomised controlled study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 72, Issue 6, 2002, Pages 708-712

  Aarsland, D ^a   Laake, K ^b   Larsen, J P ^c   Janvin, C ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Central Hospital of Stavanger   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENZYME INHIBITION; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; MALE; NAUSEA; OUTCOMES RESEARCH; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; VERTIGO; XEROSTOMIA;

EID: 0036265213     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.72.6.708     Document Type: Article

References (30)

1. The epidemiology of Parkinson's disease in the county of Rogaland, Norway
2. Frequency of dementia in Parkinson's disease
3. Risk of dementia in Parkinsan's disease: A community-based, praspective study
4. Mental symptoms in Parkinson's disease are important contributors to caregiver distress
5. Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study
6. Neuropathology of Parkinson's disease
7. A clinicopathologic study of 100 cases of Parkinson's disease
8. Alpha-synuclein cortical lewy bodies correlate with dementia in Parkinson's disease
9. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: Similarity to Parkinson's and distinction from Alzheimer disease
10. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
11. A 24-week, double-blind,placebo-controlled study of donepezil in patients with Alzheimer's disease
12. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind placebo-controlled international study
13. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia
14. Cholinesterase inhibition in Parkinson's disease
15. The clinical diagnosis of Parkinson's disease: Proposal of diagnostic subgroups classified at different levels of confidence
16. Parkinsonism: Onset, progression, and mortality
17. "Mini-Mental State": A practical method for grading the mental state of patients for the clinician
18. Donepezil therapy in clinical practice. A randomized cross-over study
19. Unified Parkinson's Disease rating scale
20. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
21. The UKU side effect rating scale. A new camprehensive rating scale far psychatrapic drugs and a cross-sectional study of side-effects in neuraleptic-treated patients
22. Consensus guidelines for the clinical diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
23. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson's disease, and dementia with Lewy bodies
24. Diagnostic criteria for Parkinson's disease
25. Cholinergic dysfunction in diseases with Lewy bodies
26. Cholinergic correlates of cognitive impairment in Parkinson's disease: Comparisons with Alzheimer's disease
27. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study